My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 175

    1.

    Being prepared: modeling the response to an anthrax attack.

    Webb GF.

    Ann Intern Med. 2005 Apr 19;142(8):667-8. No abstract available. PMID: 15838074 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Summaries for patients. What is the most cost-effective way to protect people in the event of an anthrax terror attack?

    [No authors listed]

    Ann Intern Med. 2005 Apr 19;142(8):I40. No abstract available. PMID: 15838060 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cost-effectiveness of defending against bioterrorism: a comparison of vaccination and antibiotic prophylaxis against anthrax.

    Fowler RA, Sanders GD, Bravata DM, Nouri B, Gastwirth JM, Peterson D, Broker AG, Garber AM, Owens DK.

    Ann Intern Med. 2005 Apr 19;142(8):601-10.PMID: 15838066 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Responding to a small-scale bioterrorist anthrax attack: cost-effectiveness analysis comparing preattack vaccination with postattack antibiotic treatment and vaccination.

    Schmitt B, Dobrez D, Parada JP, Kyriacou DN, Golub RM, Sharma R, Bennett C.

    Arch Intern Med. 2007 Apr 9;167(7):655-62.PMID: 17420423 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax.

    Vietri NJ, Purcell BK, Lawler JV, Leffel EK, Rico P, Gamble CS, Twenhafel NA, Ivins BE, Heine HS, Sheeler R, Wright ME, Friedlander AM.

    Proc Natl Acad Sci U S A. 2006 May 16;103(20):7813-6. Epub 2006 May 3.PMID: 16672361 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.

    Centers for Disease Control and Prevention (CDC).

    MMWR Morb Mortal Wkly Rep. 2002 Nov 15;51(45):1024-6.PMID: 12458919 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Preattack vaccination against anthrax may be cost-effective in certain populations.

    Hopkins RJ, Waytes TA, Zink TK.

    Arch Intern Med. 2008 Jan 14;168(1):114-5; author reply 115. No abstract available. PMID: 18195210 [PubMed - indexed for MEDLINE]Related articles

    8.

    Bioterrorism and compulsory vaccination: arguments for current vaccines are based on inadequate support for older vaccines.

    Schumm WR.

    BMJ. 2004 Oct 23;329(7472):977-8. No abstract available. PMID: 15499122 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Public health response to an anthrax attack: an evaluation of vaccination policy options.

    Baccam P, Boechler M.

    Biosecur Bioterror. 2007 Mar;5(1):26-34.PMID: 17437349 [PubMed - indexed for MEDLINE]Related articles

    10.

    From the Centers for Disease Control and Prevention. Additional options for preventive treatment for exposed persons to inhalational anthrax.

    [No authors listed]

    JAMA. 2002 Feb 6;287(5):579. No abstract available. PMID: 11838446 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    From the Centers for Disease Control and Prevention. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices.

    Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices.

    JAMA. 2002 Dec 4;288(21):2681-2. No abstract available. PMID: 12476914 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    A no-show vaccine--for a mere $126 million. Deal?

    Pound ET.

    US News World Rep. 2001 Oct 29;131(18):16. No abstract available. PMID: 11699229 [PubMed - indexed for MEDLINE]Related articles

    13.

    Bioterrorism and compulsory vaccination: United States continues vaccinating to keep troops healthy.

    Grabenstein JD, Winkenwerder W Jr.

    BMJ. 2004 Oct 23;329(7472):977; author reply 977. No abstract available. PMID: 15499123 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Use of anthrax vaccine in the United States.

    Advisory Committee on Immunization Practices.

    MMWR Recomm Rep. 2000 Dec 15;49(RR-15):1-20.PMID: 11145529 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Bioterrorism: what level is the threat and are vaccines the answer?

    Smith LA.

    Expert Rev Vaccines. 2004 Oct;3(5):493-5. No abstract available. PMID: 15485326 [PubMed - indexed for MEDLINE]Related articles

    16.

    Vaccines: countering anthrax: vaccines and immunoglobulins.

    Grabenstein JD.

    Clin Infect Dis. 2008 Jan 1;46(1):129-36. Review.PMID: 18171228 [PubMed - indexed for MEDLINE]Related articles

    17.

    Prevention of inhalational anthrax in the U.S. outbreak.

    Brookmeyer R, Blades N.

    Science. 2002 Mar 8;295(5561):1861. No abstract available. PMID: 11884746 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Public health vaccination policies for containing an anthrax outbreak.

    Brookmeyer R, Johnson E, Bollinger R.

    Nature. 2004 Dec 16;432(7019):901-4.PMID: 15602561 [PubMed - indexed for MEDLINE]Related articles

    19.

    Bioterrorism and compulsory vaccination.

    Jefferson T.

    BMJ. 2004 Sep 4;329(7465):524-5. No abstract available. PMID: 15345604 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Reducing mortality from anthrax bioterrorism: strategies for stockpiling and dispensing medical and pharmaceutical supplies.

    Bravata DM, Zaric GS, Holty JE, Brandeau ML, Wilhelm ER, McDonald KM, Owens DK.

    Biosecur Bioterror. 2006;4(3):244-62.PMID: 16999586 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity